Hunan Jiudian Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
April 17, 2020 at 01:40 pm
Share
Hunan Jiudian Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 924.061 million compared to CNY 801.375 million a year ago. Operating income was CNY 62.895 million compared to CNY 80.248 million a year ago. Net income was CNY 55.065 million compared to CNY 71.985 million a year ago. Basic earnings per share from continuing operations was CNY 0.23 compared to CNY 0.31 a year ago.
Hunan Jiudian Pharmaceutical Co Ltd is a company mainly engaged in research and development, production and sales of pharmaceutical preparations. The Companyâs products are comprised of pharmaceutical preparations, raw materials, pharmaceutical excipients and plant extracts, including loxoprofen sodium gel ointment, ornidazole raw materials and preparations, dirithromycin raw materials and preparations, clindamycin phosphate tablets and so on. The products are used for the treatment of bacterial infections and anti-allergy. The Company sells its products to both domestic and international markets, including Europe, South Korea, India, Russia and South America.